<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05004545</url>
  </required_header>
  <id_info>
    <org_study_id>CPEIC-06</org_study_id>
    <nct_id>NCT05004545</nct_id>
  </id_info>
  <brief_title>Compare Hemodynamic Parameters of Propofol and Sevoflurane During CPB Time in Undergoing CABG to Avoid Lactate Level</brief_title>
  <official_title>To Compare Hemodynamic Parameters of Propofol and Sevoflurane During Cardiopulmonary Bypass Time in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery to Avoid Lactate Level.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chaudhry Pervaiz Elahi Institute of Cardiology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chaudhry Pervaiz Elahi Institute of Cardiology</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hemodynamic parameters and lactate level will be on CBP during CABG surgery patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective: To compare hemodynamic parameters of propofol and sevoflurane during&#xD;
      cardiopulmonary bypass time in patients undergoing coronary artery bypass graft (CABG)&#xD;
      surgery to avoid lactate level.&#xD;
&#xD;
      Methods: One hundred and twenty six patients scheduled for CABG from May 2017 to May 2018&#xD;
      will be included in this study. Non probability consecutive sampling will be used. Patients&#xD;
      will be divided in two groups, propofol will be given to group 1, and sevoflurane will be&#xD;
      given to group 2. Age, clamp time, bypass time, mean arterial blood pressure on bypass&#xD;
      machine and lactate level will be compared between two groups. SPSS version 24 will used and&#xD;
      p value â‰¤ 0.05 will be considered as significant.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 10, 2017</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 20, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lactate level will be measured during CPB for CABG patients to see the hemodynamics parameters</measure>
    <time_frame>06 months</time_frame>
    <description>The mean pre-cross clamp lactate level and post- rewarming lactate level will be calculated to see the effect of this on the CABG patients hemodynamics during CBP</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">126</enrollment>
  <condition>Hemodynamic Instability</condition>
  <arm_group>
    <arm_group_label>group 1 Profol Infusion to CABG patients to check lactate level</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Propofol infusion according to bodyweight will be given to check lactate level on CPB</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sevoflurane will be given to group 2 to check lacate level</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sevoflurane MAC % will be given to CABG patients to check lactate level</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Propofol infusion according to body weight will be compared with sevoflurane acording to MAC % to see the lactate level and hemodynamic parameters of CABG patients</description>
    <arm_group_label>group 1 Profol Infusion to CABG patients to check lactate level</arm_group_label>
    <arm_group_label>sevoflurane will be given to group 2 to check lacate level</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        CABG&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Emergency surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kaneez Ume Farwa, FCPS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chaudhry Pervaiz Elahi Institute of Cardiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kaneez Ume Farwa, FCPS</last_name>
    <phone>+923356787214</phone>
    <email>farwatirmizi@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cardiac Surgery ICU</name>
      <address>
        <city>Multan</city>
        <state>Punjab</state>
        <zip>66100</zip>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kneez Ume Farwa, FCPS</last_name>
    </contact>
    <investigator>
      <last_name>Kaneez Ume Farwa, FCPS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 16, 2021</study_first_submitted>
  <study_first_submitted_qc>August 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 13, 2021</study_first_posted>
  <last_update_submitted>August 9, 2021</last_update_submitted>
  <last_update_submitted_qc>August 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chaudhry Pervaiz Elahi Institute of Cardiology</investigator_affiliation>
    <investigator_full_name>Muhammad Imran Khan</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>Propofol</keyword>
  <keyword>Sevoflurane</keyword>
  <keyword>hemodynamic stability</keyword>
  <keyword>Lactate level</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Ok</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>Soon</ipd_time_frame>
    <ipd_access_criteria>Ok</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

